Fructosamine
Blood0 parametersReport in 24HrsAt Home
No Fasting Required
Details
Evaluate glucose levels in patients with conditions affecting hemoglobin (e.g., anemia, hemoglobinopathies) where HbA1c may be inaccurate
₹1,199₹1,455
18% OFF
FREE:AI Insights
Fructosamine Test Information Guide
- Why is it done?
- Measures short-term blood glucose control over the past 2-3 weeks by assessing glycated serum proteins, primarily albumin
- Monitors glycemic control in patients with diabetes mellitus (Type 1 and Type 2) between HbA1c tests
- Assesses glucose control in patients with hemoglobinopathies or conditions affecting red blood cell lifespan where HbA1c is unreliable
- Evaluates glycemic control in patients with anemia or elevated hemoglobin F levels
- Detects acute changes in blood glucose levels, particularly useful when rapid glucose control assessment is needed
- Performed during routine diabetes follow-up appointments and when adjusting diabetes medications
- Normal Range
- Normal fructosamine levels: 200-285 μmol/L (or approximately 0.6-0.9 mmol/L depending on laboratory)
- Reference ranges may vary slightly between laboratories; always refer to the specific laboratory's reference interval
- Elevated levels (>285 μmol/L): Indicate suboptimal glucose control over the preceding 2-3 weeks
- Low levels (<200 μmol/L): May indicate hypoglycemia or good glycemic control; however, very low values can be associated with liver disease or malnutrition
- Units of measurement: Micromoles per liter (μmol/L) or millimoles per liter (mmol/L)
- Normal results suggest adequate glucose control during the preceding 2-3 weeks; abnormal results indicate need for therapy adjustment
- Interpretation
- Elevated Fructosamine (>285 μmol/L): Suggests inadequate glucose control; indicates average blood glucose levels have been elevated over the past 2-3 weeks; may necessitate adjustments to diabetes medications, diet, or exercise regimen; correlates with increased risk of diabetic complications
- Normal Fructosamine (200-285 μmol/L): Indicates good short-term glucose control; current diabetes management strategy is effective; routine monitoring should continue
- Low Fructosamine (<200 μmol/L): May indicate excellent glucose control or episodes of hypoglycemia; excessively low levels warrant investigation for liver disease, malnutrition, or hypoalbuminemia; in patients on insulin, may suggest risk of hypoglycemic episodes
- Factors Affecting Interpretation:
- Hypoalbuminemia: Reduces absolute fructosamine levels; kidney disease, liver disease, or malnutrition can lower results
- Hemolytic anemia: May cause falsely low readings due to decreased albumin turnover
- Acute illness: Can transiently alter fructosamine levels independent of glucose control
- Pregnancy: Increased albumin turnover may result in lower fructosamine levels; interpretation requires clinical context
- Rapid changes in glucose: Reflects recent alterations in blood glucose patterns, making it superior to HbA1c for detecting acute control changes
- Associated Organs
- Primary Organ Systems Involved:
- Pancreas: Abnormal fructosamine indicates impaired beta cell function and insulin secretion in diabetes mellitus
- Liver: Produces albumin, the primary target for glycation; liver disease affects fructosamine interpretation
- Kidneys: Dysfunction may be both a consequence of poor glycemic control and a factor affecting protein metabolism
- Medical Conditions Associated with Abnormal Results:
- Type 1 diabetes mellitus: Elevated fructosamine indicates insulin deficiency and poor glucose control
- Type 2 diabetes mellitus: Elevated levels suggest insufficient glycemic control despite oral medications or lifestyle modifications
- Gestational diabetes: Used to monitor glucose control during pregnancy
- Chronic kidney disease: Affects both fructosamine levels and glucose metabolism
- Liver cirrhosis: Causes low fructosamine due to reduced albumin synthesis
- Hypoalbuminemia: From any cause reduces fructosamine measurements
- Potential Complications from Poor Glucose Control:
- Diabetic retinopathy: Progressive vision loss from hyperglycemia-induced retinal damage
- Diabetic nephropathy: Kidney damage leading to proteinuria and chronic kidney disease
- Diabetic neuropathy: Nerve damage causing pain, numbness, and functional impairment
- Accelerated atherosclerosis: Increased cardiovascular and cerebrovascular disease risk
- Follow-up Tests
- Recommended Based on Elevated Fructosamine:
- HbA1c (Glycated hemoglobin): Confirms long-term glucose control (8-12 weeks); provides complementary information to fructosamine
- Fasting blood glucose: Assesses baseline glucose levels; helps identify nocturnal hypoglycemia or dawn phenomenon
- Random blood glucose: Detects acute hyperglycemia and evaluates current glucose status
- Continuous glucose monitoring (CGM): Provides real-time glucose trends and pattern identification
- Serum albumin: Evaluate if low fructosamine suspected to be due to hypoalbuminemia rather than improved glucose control
- Liver function tests: If low fructosamine; assesses hepatic albumin production capacity
- Monitoring for Diabetic Complications:
- Serum creatinine and estimated glomerular filtration rate (eGFR): Assess kidney function; detect diabetic nephropathy
- Urine albumin-to-creatinine ratio (UACR): Detects early diabetic kidney disease
- Lipid panel: Identifies dyslipidemia contributing to cardiovascular risk
- Dilated eye examination: Screens for diabetic retinopathy
- Monofilament testing: Detects diabetic peripheral neuropathy
- Recommended Monitoring Frequency:
- Fructosamine every 2-4 weeks: When initiating new diabetes therapy or making medication adjustments
- Every 3 months: Routine monitoring in stable patients (coinciding with HbA1c testing)
- As needed: During acute illness, pregnancy, or when rapid assessment of glucose trends is required
- Fasting Required?
- Fasting Required: No
- Fructosamine measurement is not affected by recent food intake; blood can be drawn at any time of day without regard to meals
- Special Instructions:
- No special patient preparation required for fructosamine testing alone
- If concurrent fasting blood glucose is ordered, patient must fast 8-10 hours prior (typically overnight fasting); nothing to eat or drink except water
- Medications need not be held prior to fructosamine testing; continue all diabetes medications and other prescribed drugs as usual
- Advise patient to maintain normal activity level and medication schedule on testing day
- Patient may eat and drink normally before appointment if fructosamine is the only test ordered
- Standard venipuncture precautions apply; blood collected in appropriate serum separator tube
How our test process works!
